http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#Head
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#assertion
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#provenance
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#pubinfo
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#assertion
http://purl.obolibrary.org/obo/DOID_9352
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_9352
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB09265
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association
http://www.w3.org/2000/01/rdf-schema#label
adlyxin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus adlyxin is a glucagon like peptide 1 glp 1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus 1 limitations of use 1 has not been studied in patients with chronic pancreatitis or a history of unexplained pancreatitis consider other antidiabetic therapies in patients with a history of pancreatitis not for treatment of type 1 diabetes or diabetic ketoacidosis has not been studied in combination with short acting insulin has not been studied in patients with gastroparesis and is not recommended in patients with gastroparesis limitations of use adlyxin has not been studied in patients with chronic pancreatitis or a history of unexplained pancreatitis consider other antidiabetic therapies in patients with a history of pancreatitis see warnings and precautions 5 2 adlyxin is not a substitute for insulin adlyxin is not indicated for use in patients with type 1 diabetes mellitus or for treatment of diabetic ketoacidosis the concurrent use of adlyxin with short acting insulin has not been studied and is not recommended adlyxin has not been studied in patients with gastroparesis and is not recommended in patients with gastroparesis
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB09265
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#provenance
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#pubinfo
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#sig
http://purl.org/nanopub/x/hasSignature
Msk+Jx9xoiZCmiVzTmCkoc9R3Bdc7yLFJrrflF7Zq9JyHSlazXOz/AUj64hCqv0+VHKkU6AMbhgdxKdd6dE2zNLWIbH5O+Y31KjBaEMUz13y0uu78RIEFCx4OibXuPXNXp1QPgF/M81gnjZuYHlU9RcmsPewq4I4uQfw+bgGxiA=
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg
http://purl.org/dc/terms/created
2021-07-03T14:40:18.947+02:00
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAB6ZV7WnWujSKTCdIJ7ZGU2BHiwsKKEoHAUlogMnH2jg
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs